ライフサイエンスコーパス: acquired immune deficiency

1 nsitivity, neurodegeneration, sterility, and acquired immune deficiency.

2 with different inborn errors of immunity or acquired immune deficiencies and is yet unknown in peopl

3 An acquired immune deficiency due to interferon gamma (IFN-

4 cy leads to congenital radiosensitive severe acquired immune deficiency (RS-SCID).

5 autoimmune diseases, malignant diseases, and acquired immune deficiency states (e.g., after organ tra

6 d measurements for predicting progression to acquired immune deficiency syndrome (AIDS) and all-cause

7 Patients with acquired immune deficiency syndrome (AIDS) and boys with

8 TB is increasing due to its association with acquired immune deficiency syndrome (AIDS) and the emerg

9 Severe acute respiratory syndrome (SARS) and acquired immune deficiency syndrome (AIDS) are just two

10 pportunistic pathogen of human patients with acquired immune deficiency syndrome (AIDS) causing signi

11 r chemokines that is closely associated with acquired immune deficiency syndrome (AIDS) dementia, we

12 The acquired immune deficiency syndrome (AIDS) epidemic was

13 ivary gland tissues from 55 individuals with acquired immune deficiency syndrome (AIDS) for the prese

14 10 yrs, our perception of HIV infection and acquired immune deficiency syndrome (AIDS) has changed f

15 Diarrhea in patients with acquired immune deficiency syndrome (AIDS) has proven to

16 to humans, which gave rise to HIV-1 and the acquired immune deficiency syndrome (AIDS) pandemic.

17 and CXCR4 in brain tissue from 20 pediatric acquired immune deficiency syndrome (AIDS) patients in r

18 mmon lethal opportunistic pathogen infecting Acquired Immune Deficiency Syndrome (AIDS) patients, and

19 sential for high-titer viral replication and acquired immune deficiency syndrome (AIDS) progression.

20 13%) met SCD criteria, 131 (57%) were due to acquired immune deficiency syndrome (AIDS), 25 (11%) wer

21 of co-infection on mortality from HIV and/or acquired immune deficiency syndrome (AIDS), and hepatiti

22 iagnosis mimicking Pneumocystis pneumonia in acquired immune deficiency syndrome (AIDS), and that NSI

23 rticularly in immunocompromised persons with Acquired Immune Deficiency Syndrome (AIDS), and to the d

24 complication of human immunodeficiency virus/acquired immune deficiency syndrome (AIDS), but the mech

25 n 2001 on human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), effectively

26 disease, human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), hepatitis C,

27 An animal model of acquired immune deficiency syndrome (AIDS), the simian i

28 n is a key pathogenic factor in a variety of acquired immune deficiency syndrome (AIDS)-associated di

29 Acquired immune deficiency syndrome (AIDS)-associated Ka

30 imate proportions, timing, and predictors of acquired immune deficiency syndrome (AIDS)-related and n

31 acaque monkeys develop immunosuppression and acquired immune deficiency syndrome (AIDS)-related infla

32 ted from 12 HIV-positive homosexual men with acquired immune deficiency syndrome (AIDS)-related KS (A

33 study, the presence of hydrolytic enzymes in acquired immune deficiency syndrome (AIDS)-related neuro

34 HIV+ male outpatients who had no history of acquired immune deficiency syndrome (AIDS)-related pulmo

35 process that drives clinical progression to acquired immune deficiency syndrome (AIDS).

36 d for Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS).

37 he central nervous system (CNS) pathology of acquired immune deficiency syndrome (AIDS).

38 ectious disease epidemics, including that of acquired immune deficiency syndrome (AIDS).

39 ency virus and a small animal model of human acquired immune deficiency syndrome (AIDS).

40 with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS).

41 c infectious agent observed in patients with acquired immune deficiency syndrome (AIDS).

42 ymerase chain reaction in KS associated with acquired immune deficiency syndrome (AIDS-KS), classical

43 battle against human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS).

44 ion and alcoholism along with other factors (acquired immune deficiency syndrome [AIDS]-defining even

45 and meninges from 17 macaques that developed acquired immune deficiency syndrome after infection with

46 e elevated in the plasma of individuals with acquired immune deficiency syndrome and Kaposi sarcoma.

47 tes to the immunodeficiency of patients with acquired immune deficiency syndrome and suggest that mod

48 ptoms and human immunodeficiency virus (HIV)/acquired immune deficiency syndrome are complex and not

49 ation to the progressive immunodeficiency of acquired immune deficiency syndrome are controversial, p

50 se between pediatric and adult patients with acquired immune deficiency syndrome are most likely rela

51 e to seronegative controls and patients with acquired immune deficiency syndrome but without encephal

52 several neurodegenerative diseases including acquired immune deficiency syndrome dementia complex.

53 *5802-positive individual who presented with acquired immune deficiency syndrome despite repeatedly n

54 tein DNA/MVA vaccine can help to control the acquired immune deficiency syndrome epidemic.

55 spurred by the human immunodeficiency virus/acquired immune deficiency syndrome epidemic.

56 other causes and occurrence of a particular acquired immune deficiency syndrome illness in human imm

57 In a single-center study, all HIV/acquired immune deficiency syndrome patients with comple

58 ciency virus encephalitis causes dementia in acquired immune deficiency syndrome patients.

59 gths of infection in 25% of immunosuppressed acquired immune deficiency syndrome patients.

60 oposed as a key agent in the pathogenesis of acquired immune deficiency syndrome related disorders, i

61 rium avium complex (MAC) among patients with acquired immune deficiency syndrome results from recent

62 , diabetes, and human immunodeficiency virus/acquired immune deficiency syndrome therapy, mechanical

63 ection and, potentially, as components of an acquired immune deficiency syndrome vaccine.

64 the previous 12 months and who did not have acquired immune deficiency syndrome were sequentially en

65 an immunodeficiency virus (HIV) causes AIDS (acquired immune deficiency syndrome), a disease in which

66 portunistic infections characteristic of the acquired immune deficiency syndrome, ahs been reported i

67 reases mortality, accelerates progression to acquired immune deficiency syndrome, and exacerbates tub

68 able efficacy in the rhesus macaque model of acquired immune deficiency syndrome, enabling 50% of vac

69 The feline model of human acquired immune deficiency syndrome, feline immunodefici

70 ring model for investigating Tfh role in HIV/acquired immune deficiency syndrome, given its slow rate

71 have focused on human immunodeficiency virus/acquired immune deficiency syndrome, non-communicable di

72 ncy virus 1 (HIV-1), the retroviral agent of acquired immune deficiency syndrome, requires several ho

73 under conditions that reflect those seen in acquired immune deficiency syndrome, where this cell typ

74 mmunodeficiency virus type 1 (HIV-1) develop acquired immune deficiency syndrome-associated dementia

75 Acquired immune deficiency syndrome-associated Kaposi sa

76 in 2 major epidemiologic studies of HIV and acquired immune deficiency syndrome.

77 ease was defined as CD4 of <200 cells/muL or acquired immune deficiency syndrome.

78 ed depletion of CD4(+) T cells that leads to acquired immune deficiency syndrome.

79 reverse transcriptase inhibitors (NRTIs) for acquired immune deficiency syndrome.

80 dying less often from progression of HIV to acquired immune deficiency syndrome.

81 bsence of CD4 T cells, as takes place during acquired immune deficiency syndrome.

82 e pathology of various malignancies in human acquired immune deficiency syndrome.

83 s (SIVE) in addition to immunodeficiency and acquired immune deficiency syndrome.

84 uses disseminated infection in patients with acquired immune deficiency syndrome.

85 n human immunodeficiency virus infection and acquired immune deficiency syndrome.

86 s known to be dysfunctional in patients with acquired immune deficiency syndrome.

87 infected humans underlies the development of acquired immune deficiency syndrome.

88 the development of antiviral agents against acquired immune deficiency syndrome.

89 immunosuppression and the development of the acquired immune deficiency syndrome.

90 tinitis pigmentosa, sickle cell disease, and acquired immune deficiency syndrome.

91 bone marrow transplant and in patients with acquired immune deficiency syndrome.

92 MV retinitis is facilitated in patients with acquired immune deficiency syndrome.

93 coronavirus 2 infection, tumorigenesis, and acquired immune deficiency syndrome.

94 mplicates human immunodeficiency virus (HIV)/acquired immune deficiency syndrome; however, liver path

95 HIV protease inhibitors in the treatment of acquired immune-deficiency syndrome (AIDS).

96 n and the mechanisms of SIV- and HIV-induced acquired immune-deficiency syndrome.

97 In an acquired-immune-deficiency-syndrome-related neoplasm, Ka

98 ipheral T cell pool in select congenital and acquired immune deficiency syndromes.

99 clinical isolates of HCMV from patients with acquired immune deficiency virus also productively infec